SNGX short interest
Soligenix Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 168,052 |
|---|---|
| Change vs prior report | -34,506 (-17.0%) |
| Change over six months | -74.6% |
| Days to cover | 1.00 (sector: 3.78) |
| Average daily volume | 309,467 |
| Rank in Healthcare | #779 of 922 by days to cover |
SNGX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 168,052 | -17.0% | 1.00 | 309,467 |
| 2026-09-15 | 202,558 | -3.8% | 1.58 | 128,360 |
| 2026-08-31 | 210,537 | +1.4% | 1.00 | 311,871 |
| 2026-08-14 | 207,637 | -64.5% | 1.21 | 171,039 |
| 2026-07-31 | 585,019 | +21.0% | 1.82 | 320,755 |
| 2026-07-15 | 483,436 | +18.1% | 1.09 | 445,198 |
| 2026-06-30 | 409,414 | -14.5% | 1.00 | 728,951 |
| 2026-06-15 | 479,055 | -92.7% | 1.00 | 3,609,843 |
| 2026-05-29 | 6,514,042 | +837.4% | 1.00 | 42,539,946 |
| 2026-05-15 | 694,906 | -32.0% | 1.00 | 1,052,627 |
| 2026-04-30 | 1,021,580 | +26.3% | 1.00 | 2,072,992 |
| 2026-04-15 | 809,139 | +22.2% | 5.13 | 157,625 |
| 2026-03-31 | 662,209 | +5.3% | 1.48 | 446,222 |
| 2026-03-13 | 628,951 | -8.4% | 4.55 | 138,341 |
| 2026-02-27 | 686,559 | +13.5% | 5.39 | 127,365 |
| 2026-02-13 | 604,892 | +22.6% | 3.63 | 166,650 |
| 2026-01-30 | 493,204 | +8.4% | 2.50 | 197,031 |
| 2026-01-15 | 454,993 | -12.5% | 2.50 | 182,251 |
| 2025-12-31 | 519,758 | +5.5% | 1.00 | 548,378 |
| 2025-12-15 | 492,405 | +33.0% | 1.55 | 317,539 |
| 2025-11-28 | 370,215 | -11.9% | 1.26 | 293,361 |
| 2025-11-14 | 420,050 | -28.8% | 1.59 | 263,638 |
| 2025-10-31 | 589,724 | -42.9% | 1.90 | 310,884 |
| 2025-10-15 | 1,032,156 | +742.4% | 1.00 | 3,456,769 |
| 2025-09-30 | 122,522 | -20.1% | 1.00 | 1,854,345 |
import finzdata as yf
yf.Ticker("SNGX").short_interest # every report since 2017
yf.Client().short_interest(["SNGX"], start="2018-01-01")Healthcare short interest · SNGX price history · Who owns SNGX · All short interest